Oragenics
OGEN
OGEN
16 hedge funds and large institutions have $5.67M invested in Oragenics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $6.22M → $5.67M (-$546K)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$320K | |
| 2 | +$154K | |
| 3 | +$154K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$30K |
| 5 |
HF
HRT Financial
New York
|
+$23K |
Top Sellers
| 1 | -$56K | |
| 2 | -$16K | |
| 3 | -$7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$6K |